IDH1 Overexpression Induced Chemotherapy Resistance and IDH1 Mutation Enhanced Chemotherapy Sensitivity in Glioma Cells in Vitro and in Vivo

Gamma-secretase inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and/or Bcl-xL in human colon cancer cells

(2013) Cindy R. Timme et al.   APOPTOSIS

High amounts of fluoride induce apoptosis/cell death in matured ameloblast-like LS8 cells by downregulating Bcl-2

(2013) Ting Yang et al.   ARCHIVES OF ORAL BIOLOGY

MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma

(2013) Rui-Yan Li et al.   CNS Neuroscience & Therapeutics

Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways

(2013) Congxin Dai et al.   INTERNATIONAL JOURNAL OF CANCER

NADP+-dependent IDH1R132 mutation and its relevance for glioma patient survival

(2013) Nishita M.S. Baldewpersad Tewarie et al.   MEDICAL HYPOTHESES

MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients

(2012) A M J Langers et al.   BRITISH JOURNAL OF CANCER

Control of ground-state pluripotency by allelic regulation of Nanog

(2012) Yusuke Miyanari et al.   NATURE

The Significance of MMP-9 Over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma After Curative Resection

(2011) Rongxin Chen et al.   ANNALS OF SURGICAL ONCOLOGY

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

(2011) M. P. H. M. Jansen et al.   BREAST CANCER RESEARCH AND TREATMENT

Neurosurgery for Brain Tumors: Update on Recent Technical Advances

(2011) Jonathan H. Sherman et al.   Current Neurology and Neuroscience Reports

Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients

(2011) Irena Ranogajec et al.   MEDICAL ONCOLOGY

A comprehensive outlook on intracerebral therapy of malignant gliomas

(2010) Carlo Buonerba et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas

(2009) S. Nobusawa et al.   CLINICAL CANCER RESEARCH

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

(2009) Lenny Dang et al.   NATURE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE